Batyl alcohol

Market Intelligence on Squalamine Recent Market Dynamics

I. Price Trends
1. Domestic Market: Recently, the price of domestic squalamine active pharmaceutical ingredient (API) has shown a slight upward fluctuation. The mainstream transaction price ranges from 1,200 to 1,300 yuan per kilogram, representing an increase of approximately 3% to 5% compared to the same period last month. In some regions, due to tight supply, prices have reached around 1,350 yuan per kilogram.
2. International Market: Prices in the international market remain relatively stable. However, influenced by rising global logistics costs, the landed import prices have seen a slight increase of about 2%. Current quotations are approximately 180 to 200 euros per kilogram in the European market and 220 to 240 US dollars per kilogram in the US market.

II. Supply Situation
1. Production Enterprises: The production status of major domestic squalamine manufacturers is generally normal. However, some enterprises have undergone equipment upgrades to meet enhanced environmental protection requirements, leading to a short-term decline in output. Additionally, seasonal factors affecting raw material supply have caused increases in procurement costs for certain materials, slightly dampening production enthusiasm.
2. Inventory Levels: Overall inventory remains at a low level, with both traders and manufacturers holding minimal stocks. Due to positive expectations for future prices, some traders are holding back sales, further exacerbating the tight supply situation in the market.

III. Demand Situation
1. Pharmaceutical Industry: As a key raw material for leukocytosis-promoting drugs, the demand for squalamine in the pharmaceutical sector remains stable. With the onset of winter, the prevalence of respiratory and other diseases has increased demand for related medications, thereby boosting squalamine demand. Furthermore, demand from new drug development projects is gradually materializing.
2. Other Industries: In the cosmetics and health supplement sectors, squalamine is valued for its moisturizing and antioxidant properties, leading to slow but steady demand growth. However, the proportion of demand from these two sectors relative to the total market remains relatively small.

IV. Relevant Policies and Industry Dynamics
1. Policy Aspects: The Chinese government continues to strengthen regulatory oversight of the pharmaceutical industry, with increasingly stringent quality standards for API. This has compelled squalamine manufacturers to increase investment in quality control, thereby raising production costs to some extent.
2. Industry Dynamics: Recently, some enterprises in the industry have announced plans to expand squalamine production capacity. However, the time required from construction to commissioning means these projects will have little substantive impact on market supply in the short term.

Analysis and Judgment
1. Supply Side: Due to equipment upgrades by manufacturers and raw material supply constraints, a significant increase in supply is unlikely in the short term. With low inventory levels and traders' reluctance to sell, the tight supply situation is expected to persist for some time.
2. Demand Side: Demand in the pharmaceutical industry is growing steadily, particularly driven by the winter peak season for diseases. Demand from other industries is also showing slow growth, indicating an overall positive demand trend.
3. Cost Side: Rising raw material prices and increased environmental protection investments have led to higher production costs. To maintain profit margins, enterprises have an inclination to raise prices.

Forecast
1. Price: It is expected that squalamine prices will continue a slight upward trend in the short term. The mainstream transaction price in China is likely to break through 1,350 yuan per kilogram. International prices may also rise further in line with cost increases.
2. Supply: As equipment upgrades are completed and new capacity is gradually released, the tight supply situation will ease in the medium to long term. However, the tight supply pattern is unlikely to change in the short term.
3. Demand: Demand in the pharmaceutical industry will continue to grow steadily, while demand from other sectors will also maintain a slow upward trend. Overall demand will provide strong support for prices.